Evidence map›Paper›PMID 32878165›Full record

ArticleJournal of clinical medicine2020

Correlation of Arterial CO

Tomoki Uno, Tetsuya Homma, Masahiko Shigemura, Yosuke Fukuda, Tomoyuki Kimura, Chihiro Onitsuka, Tomoko Kawahara, Hiroki Sato, Kaho Akimoto, Hiromitsu Suganuma and 26 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Tomoki UnoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Tetsuya HommaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Masahiko ShigemuraDivision of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA.ORCID 0000-0001-7767-6584
Yosuke FukudaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.ORCID 0000-0002-7087-1595
Tomoyuki KimuraDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Chihiro OnitsukaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Tomoko KawaharaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Hiroki SatoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Kaho AkimotoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Hiromitsu SuganumaDepartment of Respiratory Medicine, Asahi General Hospital, Chiba 289-2511, Japan.
Ayaka KashimaDepartment of Respiratory Medicine, Asahi General Hospital, Chiba 289-2511, Japan.
Shigenori YamamotoDepartment of Pulmonary Medicine, Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital, Tokyo 145-0065, Japan.
Takaya EbatoDepartment of Respiratory Medicine, Yamanashi Red Cross Hospital, Yamanashi 401-0301, Japan.
Tomohiro MatsunagaDepartment of Medicine, Division of Allergology and Respiratory Medicine, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Keisuke KanekoDepartment of Respiratory Medicine, Ibarakihigashi National Hospital, Ibaraki 142-0064, Japan.
Hatsuko MikuniDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Haruna SatoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Yoshitaka UchidaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.ORCID 0000-0002-7269-3956
Akiko FujiwaraRespiratory Disease Center, Showa University Northern Yokohama Hospital, Kanagawa 224-8503, Japan.
Naota KuwaharaDepartment of Medicine, Division of Allergology and Respiratory Medicine, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Ryo ManabeDepartment of Medicine, Division of Allergology and Respiratory Medicine, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Hitomi IdaDepartment of Medicine, Division of Allergology and Respiratory Medicine, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Kuniaki HiraiDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Yoshito MiyataDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Megumi JinnoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Shin OhtaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Yasunari KishinoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Hideki InoueDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.ORCID 0000-0002-8624-6524
Mayumi YamamotoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Yoshio WatanabeDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.ORCID 0000-0002-5091-8210
Sojiro KusumotoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Koichi AndoDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Shintaro SuzukiDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Akihiko TanakaDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Tohru OhmoriDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.
Hironori SagaraDepartment of Medicine, Division of Respiratory Medicine and Allergology, 1-5-8 Hatanodai, Shinagawa-ku, Showa University School of Medicine, Tokyo 142-0064, Japan.

Funding

Environment Research and Technology Development Fund year 2019 to 2021Japan Society for the Promotion of Science 18K10654Japan Society for the Promotion of Science 18K16160Japan Society for the Promotion of Science 19K24240Japan Society for the Promotion of Science 20K03161
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a respiratory illness characterized by airflow limitation and chronic respiratory symptoms with a global prevalence estimated to be more than 10% in 2010 and still on the rise. Furthermore, hypercapnic subject COPD leads to an increased risk of mortality, morbidity, and poor QoL (quality of life) than normocapnic subjects. Series of studies showed the usefulness of the forced oscillation technique (FOT) to measure small airway closure. Traditional findings suggested that hypercapnia may not be the main treating targets, but recent findings suggested that blood stream CO

Indexed as

CO2FOThypercapnia

Identifiers

PMID32878165
PMCPMC7564107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.